Recognition Dynamics of p53 and MDM2: Implications for Peptide Design

Area of Science:

• Computational biophysics and drug discovery.
• Molecular dynamics simulations of protein-peptide interactions.

Background:

• Peptides inhibiting MDM2-p53 interactions are investigated as anticancer agents.
• Understanding peptide-MDM2 binding dynamics is crucial but largely unexplored.
• Thermodynamic aspects of peptide-MDM2 interactions are well-studied.

Purpose of the Study:

• To explore the kinetics of peptide binding to MDM2 using simulations.
• To investigate the impact of C-terminal peptide substitutions on interaction dynamics.
• To compare binding mechanisms of p53-based and phage-derived peptides.

Main Methods:

• Brownian dynamics simulations were employed to analyze peptide-MDM2 interactions.
• Systematic investigation of C-terminal substitutions in p53-based and phage-derived peptides.
• Analysis of peptide residence times and binding orientations.

Main Results:

• Peptide substitutions modulated residence times; highest affinity peptide showed longest residence time (~25 μs).
• p53-based peptides exhibited kinetically driven binding, while phage-derived peptides showed thermodynamically driven binding.
• A designed R3E mutant of a phage-derived peptide demonstrated a ~5-fold increase in residence time (~120 μs) and altered binding orientation.

Conclusions:

• The R3E mutant phage-derived peptide exhibits higher affinity for MDM2, suggesting potential for competitive inhibition of MDM2-p53.
• Binding kinetics and orientation are critical determinants of peptide-MDM2 interactions.
• A novel computational framework for kinetics-based lead optimization in anticancer drug development is proposed.